EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieMultizentrische StudieÄquivalenzstudie

Sirolimus- vs Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis

Haiwei Liu, Yi Li, Guosheng Fu, Jian An, Shaoliang Chen, Zhixiong Zhong, Bin Liu, Chunguang Qiu, Likun Ma, Hongliang Cong, Hui Li, Qian Tong und 7 weitere

JACC: Cardiovascular Interventions · 2025-04 · 18 (8) · 963-971

DOI: 10.1016/j.jcin.2024.12.024 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2025-04. Verfasst von Haiwei Liu und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, People's Republic of China. Hauptthemen laut MEDLINE: Paclitaxel, Coronary Restenosis, Sirolimus, Coated Materials, Biocompatible. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PaclitaxelCoronary RestenosisSirolimusCoated Materials, BiocompatibleCardiovascular AgentsCardiac CathetersAngioplasty, Balloon, CoronaryPercutaneous Coronary InterventionStentsCoronary Artery DiseaseHumansMaleFemaleProspective StudiesMiddle AgedTreatment OutcomeAgedTime FactorsCoronary AngiographyRisk FactorsProsthesis Design

Stichwörter der Autor:innen

drug-coated balloonin-stent restenosispaclitaxelrandomized controlled trialsirolimus

Substanzen

PaclitaxelSirolimusCoated Materials, BiocompatibleCardiovascular Agents

Autor:innen und Institutionen

  • Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, People's Republic of China.
  • Sir Run Run Shaw Hospital, Hangzhou, People's Republic of China.
  • Shanxi Cardiovascular Hospital, Taiyuan, People's Republic of China.
  • Nanjing First Hospital, Nanjing Medical University, Nanjing, People's Republic of China.
  • Meizhou People's Hospital, Meizhou, People's Republic of China.
  • The Second Hospital of Jilin University, Changchun, People's Republic of China.

Zitieren

APA

Liu, H., Li, Y., Fu, G., An, J., Chen, S., Zhong, Z., Liu, B., Qiu, C., Ma, L., Cong, H., Li, H., Tong, Q., He, B., Jin, Z., Zhang, J., Yuan, H., Qiu, M., Zhang, R., & Han, Y. (2025). Sirolimus- vs Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis. JACC: Cardiovascular Interventions, 18(8), 963-971. https://doi.org/10.1016/j.jcin.2024.12.024

Vancouver

Liu H, Li Y, Fu G, An J, Chen S, Zhong Z, et al. Sirolimus- vs Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis. JACC: Cardiovascular Interventions. 2025;18(8):963-971. doi:10.1016/j.jcin.2024.12.024

BibTeX
@article{Liu2025,
  author = {Liu, Haiwei and Li, Yi and Fu, Guosheng and An, Jian and Chen, Shaoliang and Zhong, Zhixiong and Liu, Bin and Qiu, Chunguang and Ma, Likun and Cong, Hongliang and Li, Hui and Tong, Qian and He, Ben and Jin, Zening and Zhang, Jun and Yuan, Haitao and Qiu, Miaohan and Zhang, Ruiyan and Han, Yaling},
  title = {Sirolimus- vs Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis},
  journal = {JACC: Cardiovascular Interventions},
  year = {2025},
  volume = {18},
  number = {8},
  pages = {963--971},
  doi = {10.1016/j.jcin.2024.12.024}
}
Kostenlos starten →